Fintel reports that on January 23, 2025, Roth MKM initiated coverage of Innventure (NasdaqGM:INV) with a Buy recommendation.

Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM lowered the firm’s price target on SM Energy (SM) to $50 from $51 and keeps a Buy rating on the shares as part of a broader research ...

Roth MKM raised the firm’s price target on Coterra Energy (CTRA) to $33 from $30 and keeps a Buy rating on the shares as part of a broader ...

IMAX (NYSE:IMAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy ...

Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Redwire in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst A. Sheppard ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...

On Wednesday, Hecla Mining Co (HL) stock saw a decline, ending the day at $5.48 which represents a decrease of $-0.10 or -1.79% from the prior close of $5.58. The stock opened at $5.59 and touched a ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...